psoriatic arthritis

Biocon Biologics’ Ustekinumab Biosimilar receives positive CHMP opinion

Read more

Biocon Biologics receives FDA approval for biosimilar YESINTEK

Read more

Biocon Biologics gets US market entry date for Bmab 1200, a proposed biosimilar to Stelara

Read more

Eli Lilly launches Copellor in India to treat moderate-to-severe plaque psoriasis

Read more

Shilpa Medicare gets US FDA tentative nod for Apremilast Tablets

Read more

Cadila Pharma launches Cadalimab (adalimumab biosimilar) for India

Read more

Novartis arthritis drug fails to prove it is significantly better than rival

Read more